Cargando…

Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake

BACKGROUND: With neurogenetic and epigenetic tools utilized in research and neuroimaging, we are unraveling the mysteries of brain function, especially as it relates to Reward Deficiency (RDS). We encourage the development of pharmaceuticals or nutraceuticals that promote a reduction in dopamine res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duquette, Lucien L, Mattiace, Frank, Blum, Kenneth, Waite, Roger L, Boland, Teresa, McLaughlin, Thomas, Dushaj, Kristina, Febo, Marcelo, Badgaiyan, Rajendra D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714519/ https://www.ncbi.nlm.nih.gov/pubmed/29214221 http://dx.doi.org/10.23937/2378-3656/1410104

Ejemplares similares

Hypothesizing that a Pro-Dopaminergic Regulator (KB220z(™) Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence
por: Blum, Kenneth, et al.
Publicado: (2016)

KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?
por: McLaughlin, Thomas, et al.
Publicado: (2016)

Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS)
por: Blum, Kenneth, et al.
Publicado: (2017)

Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality
por: Blum, Kenneth, et al.
Publicado: (2015)

Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term
por: Blum, Kenneth, et al.
Publicado: (2016)

Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
por: Febo, Marcelo, et al.
Publicado: (2017)

Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD
por: McLaughlin, Thomas, et al.
Publicado: (2018)

“Pro-dopamine regulation (KB220Z™)” as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America
por: Blum, K, et al.
Publicado: (2016)

Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual
por: Blum, Kenneth, et al.
Publicado: (2020)

Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission
por: Blum, Kenneth, et al.
Publicado: (2017)

Putative Dopamine Agonist (KB220Z) Attenuates Lucid Nightmares in PTSD Patients: Role of Enhanced Brain Reward Functional Connectivity and Homeostasis Redeeming Joy
por: McLaughlin, Thomas, et al.
Publicado: (2015)

Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis
por: McLaughlin, Thomas, et al.
Publicado: (2015)

VTA-NAc glutaminergic projection involves in the regulation of pain and pain-related anxiety
por: Abdul, Mannan, et al.
Publicado: (2022)

Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated)
por: Kenneth, Blum, et al.
Publicado: (2018)

Evidence of Dopaminergic Processing of Executive Inhibition
por: Badgaiyan, Rajendra D., et al.
Publicado: (2011)

“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation
por: Blum, Kenneth, et al.
Publicado: (2022)

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
por: Blum, Kenneth, et al.
Publicado: (2017)

Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms
por: Blum, Kenneth, et al.
Publicado: (2015)

Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?
por: McLaughlin, Thomas, et al.
Publicado: (2017)

Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic
por: Beitscher-Campbell, Harriet, et al.
Publicado: (2016)

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids
por: Ceccanti, Mauro, et al.
Publicado: (2022)

KB-Rank: efficient protein structure and functional annotation identification via text query
por: Julfayev, Elchin S., et al.
Publicado: (2012)

Dopaminergic Input to the Inferior Colliculus in Mice
por: Nevue, Alexander A., et al.
Publicado: (2016)

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
por: Blum, Kenneth, et al.
Publicado: (2015)

CompTIA A+: exams A+ essentials (220-601), 220-602, 220-603, 220-604
por: Brooks, Charles J, et al.
Publicado: (2008)

Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS)
por: Blum, Kenneth, et al.
Publicado: (2020)

Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management”
por: Blum, Kenneth, et al.
Publicado: (2022)

Control of Sleep by Dopaminergic Inputs to the Drosophila Mushroom Body
por: Sitaraman, Divya, et al.
Publicado: (2015)

Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?
por: Blum, Kenneth, et al.
Publicado: (2014)

CompTIA A+ 220-901 and 220-902
por: Prowse, David L
Publicado: (2016)

CompTIA A+ 220-801 and 220-802
por: Prowse, David L
Publicado: (2013)

CompTIA A+: 220-701 and 220-702
por: Prowse, David L
Publicado: (2011)

A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain
por: Blum, Kenneth, et al.
Publicado: (2014)

Calvin klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge a potential death sentence
por: Gold, Mark S, et al.
Publicado: (2020)

CompTIA A+ practice questions: essentials, exams 220-602, 220-603, 220-604
por: Brooks, Charles J
Publicado: (2008)

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
por: Blum, Kenneth, et al.
Publicado: (2015)

Neuroligin‐3 in dopaminergic circuits promotes behavioural and neurobiological adaptations to chronic morphine exposure
por: Brandner, Dieter D., et al.
Publicado: (2022)

Lack of Dopaminergic Inputs Elongates the Primary Cilia of Striatal Neurons
por: Miyoshi, Ko, et al.
Publicado: (2014)

Orexinergic Input to Dopaminergic Neurons of the Human Ventral Tegmental Area
por: Hrabovszky, Erik, et al.
Publicado: (2013)

Corrigendum: Control of Sleep by Dopaminergic Inputs to the Drosophila Mushroom Body
por: Sitaraman, Divya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gbv09clsbc1kt752v4dpru4v7n